window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-113618785-2');
Home2019-03-05T16:46:01+00:00
Loading...

The COLOSSUS Project

Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.

For more details about this innovative project and our aims see here.

Project Partners

The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.

Latest News

Partner in the Spotlight: Halio Dx

May 12th, 2020|

This month we feature our partners at HalioDx. HalioDx (https://www.haliodx.com/) is the pioneer of immuno-oncology diagnostic, a transforming approach of cancer care that benefits from novel and deep understanding of the tumour immune microenvironment. The [...]

COLOSSUS Partner in the Spotlight: Cancer Trials Ireland

April 9th, 2020|

Cancer Trials Ireland was established in 1996 under the name of Irish Cooperative Oncology Research Group (ICORG). A group of cancer consultants had the aim to create more opportunities for patients to access cutting edge [...]

VIEW NEWS